Connect with us

BIOTECH

Axim Biotechnologies Inc (OTCMKTS:AXIM) Makes Changes To Advisory Board

Published

on

Axim Biotechnologies Inc (OTCMKTS:AXIM) updated on the changes made to its advisory board. The firm has elected Dr. Donald Abrams as a new member to the board. Currently he is the Chief of the Hematology-Oncology segment at San Francisco General Hospital

The details

George E. Anastassov, MD, who is the CEO of Axim, mentioned that they are honored and exhilarated to have Dr. Abrams become a part of their Advisory Board. In addition to being an oncology professional who was one of the initial clinicians to spot and define different AIDS-related issues, Dr. Abrams has expertise in medicinal cannabis research as well as clinical studies. Now with Axim, he will work to further enhance the intellectual rigor of firm’s research and help meet people needs with Hemp related pharmaceutical solutions.

Commenting on his role with Axim, Dr. Abrams mentioned that he is exhilarated to be joining the advisory board as he is enthralled with firm’s unique technology aiming to formulate cannabis-based drugs accessible to patients via its fresh delivery mechanisms.

The next big cannabis story to hit North America is Phoenix Life Science International (PLSI), traded in the US, but with the largest global production based in the tropics and a license to distribute worldwide. Take a look at Phoenix Life Science International PLSI), Its currently trading under $18 dollars per share on the OTC markets. Learn More Now!

Dr. Abrams has been a part of clinical studies of unconventional and complementary drug intrusions for AIDS/ HIV and cancer, counting assessments of medical marijuana. He obtained financial support in 1997 from the “National Institute on Drug Abuse” to carry out clinical studies of the provisional safety of Hemps in HIV infection.

Axim posted that Dr. Abrams completed a pivotal trial of smoked cannabis in subjects with HIV-linked peripheral neuropathy and a study evaluating vaporization as a smokeless delivery tool for medicinal purposes.

Dr. Abram’s NIDA-supported study evaluated the probable pharmacokinetic contact between opioid analgesics and vaporized cannabis in subjects with chronic pain. He has been performing an NIH-funded trial evaluating vaporized cannabis in subjects with Sickle Cell disease.

In the last trading session, the stock price of Axim gained more than 4% to close the day at $12.10.

Pushing the barriers for global distribution, Phoenix Life Science International (PLSI) is the next cannabis play. Just think Canopy x 100, that is how big their plantation in the tropics will be. No lights, no green houses, just maximum growth + minimal cost = home run. Learn More Now!

   

Learn More About PLSI at your brokerage today!

         

TRENDING STORIES

INDUSTRIAL HEMP5 months ago

Auxly Cannabis Group Inc (OTCMKTS:CBWTF) Acquires 46% Stake In Curative Cannabis And Agrees to Fund Cannabis Cultivation Facility To Produce Ultra Premium Cannabis

Auxly Cannabis Group Inc (OTCMKTS:CBWTF) has entered a deal to take over a 46% stake in Curative Cannabis. The company...

INDUSTRIAL HEMP5 months ago

Canntrust Holdings Inc. (OTCMKTS:CNTTF) Receive Permission From The Town Of Pelham For Their Third Phase Construction

CannTrust Holdings Inc. (OTCMKTS:CNTTF) has announced that they have obtained the required permit to go on with the third phase...

INDUSTRIAL HEMP5 months ago

Indiva Ltd (OTCMKTS:NDVAF) Announces 9.9% Equity Investment In Retailgo Inc.

Indiva Ltd (OTCMKTS:NDVAF) has announced that they are delighted to have finalized an Equity investment of 9.9% in RetailGo Inc....

INDUSTRIAL HEMP5 months ago

Future Farm Technologies Inc (OTCMKTS:FFRMF) Plans To Begin Selling Of Cheery Wine Strain Hemp Seeds And Test Operation Of The Oil Extraction Equipment

Future Farm Technologies Inc (OTCMKTS:FFRMF) is planning to commence the selling of the elite cherry Wine hemp seeds by putting...

INDUSTRIAL HEMP5 months ago

OrganiGram Holdings Inc (OTCMKTS:OGRMF) Sources Hemp With High Levels of CBD From 1812 Hemp

OrganiGram Holdings Inc (OTCMKTS:OGRMF) has entered into a supply pact with 1812 Hemp, an industrial hemp research company based in...

INDUSTRIAL HEMP5 months ago

Kona Gold Solutions Inc (OTCMKTS:KGKG) Declares That They Have Acquired Gold Leaf Distribution

Kona Gold Solutions Inc (OTCMKTS:KGKG) has announced the acquisition of Gold Leaf distribution a newly established distribution company. The Florida...

INDUSTRIAL HEMP5 months ago

CFN Media Group features Supreme Cannabis Company (OTCMKTS:SPRWF) as consideration for investors as their 2019 stock scales up

CFNB Media Group has announced a publication on Supreme Cannabis Company (OTCMKTS:SPRWF) as a licensed producer obsessed with quality. Supreme...

INDUSTRIAL HEMP5 months ago

Village Farms International Inc (OTCMKTS:VFFIF) Leading Greenhouse Crop Protection And Announces Plans To List Its Common Shares On The NASDAQ Market

Village Farms International Inc (OTCMKTS:VFFIF) has announced that they have facilitated Health Canada Pest Management Agency to get approval for...

INDUSTRIAL HEMP5 months ago

Sunniva Inc. (OTCMKTS:SNNVF) Secures More Funding For Growth Strategy As Plans Solidify Towards A Tremendous Year

Sunniva Inc. (OTCMKTS:SNNVF) is solidifying its growth strategy in anticipation for exponential growth this year. Notably, the firm acquired a...

INDUSTRIAL HEMP5 months ago

Curis, Inc. (NASDAQ:CRIS) Announce The Dosing Of The First Mesothelioma Patient In The First Phase Of The CA-170 Study

Curis, Inc. (NASDAQ:CRIS) has announced the enrolment and dosing of the first mesothelioma patient in the first phase of the...

Advertisement

Create a future where the human body can repair, restore, and rejuvenate itself

 

Trading Symbol

OTC: PLSI

The Next Big Global Cannabis Play